We are live on ! Find out more
O

OppenheimerFunds Portfolio holdings

AUM $80.4B
1-Year Est. Return 15.1%
This Fund
S&P 500
This Quarter Est. Return
+19.35%
1 Year Est. Return
+15.1%
3 Year Est. Return
+72.05%
5 Year Est. Return
+91.1%
10 Year Est. Return
–
AUM
$80.4B
AUM Growth
+$10.3B
Cap. Flow
-$1.63B
Cap. Flow %
-2.03%
Top 10 Hldgs %
17.35%
Holding
1,869
New
81
Increased
811
Reduced
837
Closed
124

Top Buys

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$355M
2
YUMC icon
Yum China
YUMC
+$307M
3
ELAN icon
Elanco Animal Health
ELAN
+$298M
4
WES icon
Western Midstream Partners
WES
+$238M
5
ENLC
ENLINK MIDSTREAM, LLC
ENLC
+$137M

Top Sells

Rank Stock Value
1
PDD icon
Pinduoduo
PDD
+$291M
2
PEP icon
PepsiCo
PEP
+$260M
3
BNY
Bank of New York Mellon
BNY
+$258M
4
AAPL icon
Apple
AAPL
+$221M
5
WES
Western Gas Partners Lp
WES
+$215M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 16.81%
2 Technology 15.13%
3 Energy 13.68%
4 Healthcare 13.59%
5 Financials 12.24%

No holdings matched the selected filter criteria.

71 72 73 74 75

Similar funds

TA
Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
SBAM
Santa Barbara Asset Management Los Angeles, California $6.43B AUM 10.99% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
SA
SQ Advisors Naples, Florida $1.32B AUM 10.3% 1-Year Est. Return
WF
WealthTrust Fairport Cleveland, Ohio $1.06B AUM 3.47% 1-Year Est. Return
BCPEM
Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return

OppenheimerFunds's Q1 2019 Portfolio in Review

As of Q1 2019, OppenheimerFunds held 1,869 positions worth $80.4B, up 15% from $70.1B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

OppenheimerFunds's Q1 2019 filing shows 81 new, 811 increased, 837 reduced and 124 closed positions. Its largest new stake was Elanco Animal Health: 9,668,160 shares worth $310M. The largest sale was Pinduoduo, an estimated $291M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, up from 15% a quarter earlier, followed by Technology and Energy.

  • OppenheimerFunds's largest Q1 2019 buy was Elanco Animal Health: 9,668,160 shares worth $310M.
  • OppenheimerFunds added most to Procter & Gamble in Q1 2019, an estimated $355M increase.
  • OppenheimerFunds's biggest Q1 2019 reduction was Pinduoduo, cutting an estimated $291M.
  • OppenheimerFunds fully exited Western Gas Partners Lp in Q1 2019, selling an estimated $215M.
  • OppenheimerFunds's ten largest holdings make up 17% of its $80.4B portfolio in Q1 2019.
  • OppenheimerFunds opened 81 new positions and closed 124 in Q1 2019.
  • OppenheimerFunds's portfolio value rose 15% quarter-over-quarter to $80.4B.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.